Patricia M. Danzon

Patricia Danzon is the Celia Moh Professor Emeritus at The Wharton School, University of Pennsylvania. She received a B.A. from Oxford University, England, and a Ph.D. in Economics from the University of Chicago. Professor Danzon is an internationally recognized expert in the economics of health care, the biopharmaceutical industry, and insurance. She is a member of the National Academy of Medicine and a former Research Associate at the National Bureau of Economic Research. She has served as a consultant to many governmental agencies, NGOs and private corporations in the US and internationally. Professor Danzon has been an Associate Editor of the American Economic Review, the Journal of Health Economics and the International Journal of Health Care Finance and Economics. She has published widely in scholarly journals on a broad range of subjects related to health care, pharmaceuticals, biotechnology, insurance, and the economics of law.

Why the FTC Should Consider Size in Drug Mergers

Large pharmaceutical firms retain their dominance through size-related advantages in three areas: contracting, marketing and selling, and financing. When reviewing pharmaceutical mergers,...

Latest news

Startup Acquisitions Have Undecided Effects on Innovation and Economic Growth

Startups are a major driver of innovation, but many startups are acquired by large incumbents. Do these acquisitions stifle innovation or promote...

History Shows that Voluntary ESG Standards Lead to a More Focused ESG Disclosure

In recent years, ESG reports have become more common for publicly traded companies. However, critics have found the information they provide to...

Letters that Matter: How Interest Groups Shape Financial Legislation

Members of Congress are inundated with an avalanche of correspondence on a daily basis. But what persuades them to heed the call?...

Are There Really Gender Pay Differences in the CEO Labor Market?

The gender pay gap is a well-documented phenomenon in global labor markets, but this gap does not seem to apply to the...

How Many Banks Are at Risk of Insolvency Right Now?

Given the recent banking turmoil and failure of SVB and Signature and issues in First Republic, it is important to understand the...

The Challenges of Regulating Disinformation

In response to rising concerns about political disinformation, governments have introduced a slew of interventions. Federico Vaccari warns in new research that...

India’s Evolving Industrial Policy Is Critical for Realizing Its Development Vision

Industrial policy was once so out of fashion that it was jokingly called “the policy that shall not be named.” Now it’s...